2024.10.08 Press release SONIRE’s HIFU therapy system has been designated as a Breakthrough Device by FDA
2023.09.08 Grand Notice of Adoption being seleced for “Deep Tech Startup Support Program” by New Energy and Industrial Technology Development Organization (NEDO)
2023.04.13 Event SONIRE’s Clinical Trial Protocol for HIFU therapy in Pancreatic Cancer to be Presented at ISTU2023
2023.01.31 Press release Announcement of First Patient Enrolled in a Randomized Phase 2 study of SONIRE’s Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan
